Yonwoo Jung
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Yonwoo Jung has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Marina R. Picciotto
Department of Psychiatry, Yale University, 34 Park Street, New Haven, CT 06508, USA
4 shared publications - David Goldman
National Institute on Alcohol Abuse and Alcoholism
3 shared publications - Angela M. Lee
Department of Biology and
2 shared publications Angelique Bordey
Department of Neurosurgery, Yale University School of Medicine, New Haven, Connecticut, USA
1 shared publication- Christopher J. Heath
School of Life, Health and Chemical Sciences, The Open University, Walton Hall, Milton Keynes, MK7 6AA, UK
1 shared publication Daniel Coman
Department of Radiology &Biomedical Imaging Magnetic Resonance Research Center, Yale University School of Medicine, New Haven, Connecticut, USA
1 shared publication
Latest Publications
- 1 November 2020
- Published by Elsevier in Biological Psychiatry
- Vol. 88 (10) , e45-e47
“Coding” Is Not Enough: The Role of Long “Noncoding” RNA for Cocaine Addiction
- 1 November 2020
- Published by Elsevier in Biological Psychiatry
- Vol. 88 (10) , e45-e47
“Coding” Is Not Enough: The Role of Long “Noncoding” RNA for Cocaine Addiction
- Open Access
- 1 November 2019
- Published by American Medical Association (AMA) in JAMA Network Open
- Vol. 2 (11) , e1914940
Assessment of the Association of D2 Dopamine Receptor Gene and Reported Allele Frequencies With Alcohol Use Disorders
Whether the dopamine D2 receptor gene (DRD2) is associated with alcohol use disorder (AUD) and other behavioral phenotypes is a long-standing controversy. This discussion is driven by the role of 1 single-nucleotide polymorphism (SNP), rs1800497, which is located in a nearby gene, ANKK1. This SNP, from among hundreds now known in the DRD2 region, was assayable as a restriction fragment–length polymorphism (RFLP) in 1990, when the association of DRD2 and other genes with alcoholism was first examined.1 Newer technologies enabling large-scale genotyping of hundreds of SNPs in the DRD2 region, and hundreds of thousands of SNPs genome-wide, have been applied in genome-wide association studies (GWAS) of many phenotypes, including AUD2,3 and related phenotypes,4 such as brain dopamine D2 binding potential.5-7 The disproportionate focus on rs1800497 has been amplified by positive meta-analyses, such that approximately 20 studies on the association between rs1800497 and AUD have been published per decade since 1990.
- 1 November 2019
- Published by American Medical Association (AMA) in JAMA Network Open
- Vol. 2 (11) , e1914940
Open AccessAssessment of the Association of D2 Dopamine Receptor Gene and Reported Allele Frequencies With Alcohol Use Disorders
Whether the dopamine D2 receptor gene (DRD2) is associated with alcohol use disorder (AUD) and other behavioral phenotypes is a long-standing controversy. This discussion is driven by the role of 1 single-nucleotide polymorphism (SNP), rs1800497, which is located in a nearby gene, ANKK1. This SNP, from among hundreds now known in the DRD2 region, was assayable as a restriction fragment–length polymorphism (RFLP) in 1990, when the association of DRD2 and other genes with alcoholism was first examined.1 Newer technologies enabling large-scale genotyping of hundreds of SNPs in the DRD2 region, and hundreds of thousands of SNPs genome-wide, have been applied in genome-wide association studies (GWAS) of many phenotypes, including AUD2,3 and related phenotypes,4 such as brain dopamine D2 binding potential.5-7 The disproportionate focus on rs1800497 has been amplified by positive meta-analyses, such that approximately 20 studies on the association between rs1800497 and AUD have been published per decade since 1990.
- Open Access
- 15 March 2018
- Published by Wiley in Genes, Brain and Behavior
- Vol. 17 (3) , e12444
Role of RNA modifications in brain and behavior
Much progress in our understanding of RNA metabolism has been made since the first RNA nucleoside modification was identified in 1957. Many of these modifications are found in noncoding RNAs but recent interest has focused on coding RNAs. Here, we summarize current knowledge of cellular consequences of RNA modifications, with a special emphasis on neuropsychiatric disorders. We present evidence for the existence of an “RNA code,” similar to the histone code, that fine‐tunes gene expression in the nervous system by using combinations of different RNA modifications. Unlike the relatively stable genetic code, this combinatorial RNA epigenetic code, or epitranscriptome, may be dynamically reprogrammed as a cause or consequence of psychiatric disorders. We discuss potential mechanisms linking disregulation of the epitranscriptome with brain disorders and identify potential new avenues of research.
- 15 March 2018
- Published by Wiley in Genes, Brain and Behavior
- Vol. 17 (3) , e12444
Open AccessRole of RNA modifications in brain and behavior
Much progress in our understanding of RNA metabolism has been made since the first RNA nucleoside modification was identified in 1957. Many of these modifications are found in noncoding RNAs but recent interest has focused on coding RNAs. Here, we summarize current knowledge of cellular consequences of RNA modifications, with a special emphasis on neuropsychiatric disorders. We present evidence for the existence of an “RNA code,” similar to the histone code, that fine‐tunes gene expression in the nervous system by using combinations of different RNA modifications. Unlike the relatively stable genetic code, this combinatorial RNA epigenetic code, or epitranscriptome, may be dynamically reprogrammed as a cause or consequence of psychiatric disorders. We discuss potential mechanisms linking disregulation of the epitranscriptome with brain disorders and identify potential new avenues of research.
- Open Access
- 28 June 2017
- Published by Springer Nature in Scientific Reports
- Vol. 7 (1) , 1-10
Maternal smoking and autism spectrum disorder: meta-analysis with population smoking metrics as moderators
While exposure to nicotine during developmental periods can significantly affect brain development, studies examining the association between maternal smoking and autism spectrum disorder (ASD) in offspring have produced conflicting findings, and prior meta-analyses have found no significant association. Our meta-analysis used a novel approach of investigating population-level smoking metrics as moderators. The main meta-analysis, with 22 observational studies comprising 795,632 cases and 1,829,256 control participants, used a random-effects model to find no significant association between maternal smoking during pregnancy and ASD in offspring (pooled odds ratio (OR) = 1.16, 95% CI: 0.97–1.40). However, meta-regression analyses with moderators were significant when we matched pooled ORs with adult male smoking prevalence (z = 2.55, p = 0.01) in each country, using World Health Organization data. Our study shows that using population-level smoking metrics uncovers significant relationships between maternal smoking and ASD risk. Correlational analyses show that male smoking prevalence approximates secondhand smoke exposure. While we cannot exclude the possibility that our findings reflect the role of paternal or postnatal nicotine exposure, as opposed to maternal or in utero nicotine exposure, this study underlines the importance of investigating paternal and secondhand smoking in addition to maternal smoking in ASD.
- 28 June 2017
- Published by Springer Nature in Scientific Reports
- Vol. 7 (1) , 1-10
Open AccessMaternal smoking and autism spectrum disorder: meta-analysis with population smoking metrics as moderators
While exposure to nicotine during developmental periods can significantly affect brain development, studies examining the association between maternal smoking and autism spectrum disorder (ASD) in offspring have produced conflicting findings, and prior meta-analyses have found no significant association. Our meta-analysis used a novel approach of investigating population-level smoking metrics as moderators. The main meta-analysis, with 22 observational studies comprising 795,632 cases and 1,829,256 control participants, used a random-effects model to find no significant association between maternal smoking during pregnancy and ASD in offspring (pooled odds ratio (OR) = 1.16, 95% CI: 0.97–1.40). However, meta-regression analyses with moderators were significant when we matched pooled ORs with adult male smoking prevalence (z = 2.55, p = 0.01) in each country, using World Health Organization data. Our study shows that using population-level smoking metrics uncovers significant relationships between maternal smoking and ASD risk. Correlational analyses show that male smoking prevalence approximates secondhand smoke exposure. While we cannot exclude the possibility that our findings reflect the role of paternal or postnatal nicotine exposure, as opposed to maternal or in utero nicotine exposure, this study underlines the importance of investigating paternal and secondhand smoking in addition to maternal smoking in ASD.
- 30 May 2016
- Published by Springer Nature in Nature Neuroscience
- Vol. 19 (7) , 905-914
An epigenetic mechanism mediates developmental nicotine effects on neuronal structure and behavior
Developmental nicotine exposure causes persistent changes in cortical neuron morphology and in behavior. We used microarray screening to identify master transcriptional or epigenetic regulators mediating these effects of nicotine and discovered increases in Ash2l mRNA, encoding a component of a histone methyltransferase complex. We therefore examined genome-wide changes in trimethylation of histone H3 on Lys4 (H3K4me3), a mark induced by the Ash2l complex associated with increased gene transcription. A large proportion of regulated promoter sites were involved in synapse maintenance. We found that Mef2c interacts with Ash2l and mediates changes in H3K4me3. Knockdown of Ash2l or Mef2c abolished nicotine-mediated alterations of dendritic complexity in vitro and in vivo, and attenuated nicotine-dependent changes in passive avoidance behavior. In contrast, overexpression mimicked nicotine-mediated alterations of neuronal structure and passive avoidance behavior. These studies identify Ash2l as a target induced by nicotinic stimulation that couples developmental nicotine exposure to changes in brain epigenetic marks, neuronal structure and behavior.
- 30 May 2016
- Published by Springer Nature in Nature Neuroscience
- Vol. 19 (7) , 905-914
An epigenetic mechanism mediates developmental nicotine effects on neuronal structure and behavior
Developmental nicotine exposure causes persistent changes in cortical neuron morphology and in behavior. We used microarray screening to identify master transcriptional or epigenetic regulators mediating these effects of nicotine and discovered increases in Ash2l mRNA, encoding a component of a histone methyltransferase complex. We therefore examined genome-wide changes in trimethylation of histone H3 on Lys4 (H3K4me3), a mark induced by the Ash2l complex associated with increased gene transcription. A large proportion of regulated promoter sites were involved in synapse maintenance. We found that Mef2c interacts with Ash2l and mediates changes in H3K4me3. Knockdown of Ash2l or Mef2c abolished nicotine-mediated alterations of dendritic complexity in vitro and in vivo, and attenuated nicotine-dependent changes in passive avoidance behavior. In contrast, overexpression mimicked nicotine-mediated alterations of neuronal structure and passive avoidance behavior. These studies identify Ash2l as a target induced by nicotinic stimulation that couples developmental nicotine exposure to changes in brain epigenetic marks, neuronal structure and behavior.
- 21 November 2012
- Published by Springer Nature in Neuropsychopharmacology
- Vol. 38 (4) , 628-638
The Synaptic Adhesion Molecule SynCAM 1 Contributes to Cocaine Effects on Synapse Structure and Psychostimulant Behavior
Drugs of abuse have acute and persistent effects on synapse structure and addiction-related behaviors. Trans-synaptic interactions can control synapse development, and synaptic cell adhesion molecule (SynCAM) proteins (also named nectin-like molecules) are immunoglobulin adhesion proteins that span the synaptic cleft and induce excitatory synapses. Our studies now reveal that the loss of SynCAM 1 in knockout (KO) mice reduces excitatory synapse number in nucleus accumbens (NAc). SynCAM 1 additionally contributes to the structural remodeling of NAc synapses in response to the psychostimulant cocaine. Specifically, we find that cocaine administration increases the density of stubby spines on medium spiny neurons in NAc, and that maintaining this increase requires SynCAM 1. Furthermore, mushroom-type spines on these neurons are structurally more plastic when SynCAM 1 is absent, and challenging drug-withdrawn mice with cocaine shortens these spines in SynCAM 1 KO mice. These effects are correlated with changes on the behavioral level, where SynCAM 1 contributes to the psychostimulant effects of cocaine as measured after acute and repeated administration, and in drug-withdrawn mice. Together, our results provide evidence that the loss of a synapse-organizing adhesion molecule can modulate cocaine effects on spine structures in NAc and increases vulnerability to the behavioral actions of cocaine. SynCAM-dependent pathways may therefore represent novel points of therapeutic intervention after exposure to drugs of abuse.
- 21 November 2012
- Published by Springer Nature in Neuropsychopharmacology
- Vol. 38 (4) , 628-638
The Synaptic Adhesion Molecule SynCAM 1 Contributes to Cocaine Effects on Synapse Structure and Psychostimulant Behavior
Drugs of abuse have acute and persistent effects on synapse structure and addiction-related behaviors. Trans-synaptic interactions can control synapse development, and synaptic cell adhesion molecule (SynCAM) proteins (also named nectin-like molecules) are immunoglobulin adhesion proteins that span the synaptic cleft and induce excitatory synapses. Our studies now reveal that the loss of SynCAM 1 in knockout (KO) mice reduces excitatory synapse number in nucleus accumbens (NAc). SynCAM 1 additionally contributes to the structural remodeling of NAc synapses in response to the psychostimulant cocaine. Specifically, we find that cocaine administration increases the density of stubby spines on medium spiny neurons in NAc, and that maintaining this increase requires SynCAM 1. Furthermore, mushroom-type spines on these neurons are structurally more plastic when SynCAM 1 is absent, and challenging drug-withdrawn mice with cocaine shortens these spines in SynCAM 1 KO mice. These effects are correlated with changes on the behavioral level, where SynCAM 1 contributes to the psychostimulant effects of cocaine as measured after acute and repeated administration, and in drug-withdrawn mice. Together, our results provide evidence that the loss of a synapse-organizing adhesion molecule can modulate cocaine effects on spine structures in NAc and increases vulnerability to the behavioral actions of cocaine. SynCAM-dependent pathways may therefore represent novel points of therapeutic intervention after exposure to drugs of abuse.
- 29 October 2012
- Published by Wiley in European Journal of Neuroscience
- Vol. 37 (1) , 1-9
Constitutive knockout of the membrane cytoskeleton protein beta adducin decreases mushroom spine density in the nucleus accumbens but does not prevent spine remodeling in response to cocaine
The adducin family of proteins associates with the actin cytoskeleton in a calcium‐dependent manner. Beta adducin (βAdd) is involved in synaptic plasticity in the hippocampus; however, the role of βAdd in synaptic plasticity in other brain areas is unknown. Using diolistic labeling with the lipophilic dye DiI, we found that the density of mature mushroom‐shaped spines was significantly decreased in the nucleus accumbens (NAc) in brain slices from βAdd‐knockout (KO) mice as compared to their wildtype (WT) siblings. The effect of 10 days of daily cocaine (15 mg/kg) administration on NAc spine number and locomotor behavior was also measured in βAdd WT and KO mice. As expected, there was a significant increase in overall spine density in NAc slices from cocaine‐treated WT mice at this time‐point; however, there was a greater increase in the density of mushroom spines in βAdd‐KO animals following chronic cocaine administration than in WT. In addition, βAdd‐KO mice showed elevated locomotor activity in response to cocaine treatment compared to WT siblings. These results indicate that βAdd is required for stabilising mature spines under basal conditions in the NAc, but that lack of this protein does not prevent synaptic remodeling following repeated cocaine administration. In addition, these data are consistent with previous studies suggesting that βAdd may normally be involved in stabilising spines once drug‐ or experience‐dependent remodeling has occurred.
- 29 October 2012
- Published by Wiley in European Journal of Neuroscience
- Vol. 37 (1) , 1-9
Constitutive knockout of the membrane cytoskeleton protein beta adducin decreases mushroom spine density in the nucleus accumbens but does not prevent spine remodeling in response to cocaine
The adducin family of proteins associates with the actin cytoskeleton in a calcium‐dependent manner. Beta adducin (βAdd) is involved in synaptic plasticity in the hippocampus; however, the role of βAdd in synaptic plasticity in other brain areas is unknown. Using diolistic labeling with the lipophilic dye DiI, we found that the density of mature mushroom‐shaped spines was significantly decreased in the nucleus accumbens (NAc) in brain slices from βAdd‐knockout (KO) mice as compared to their wildtype (WT) siblings. The effect of 10 days of daily cocaine (15 mg/kg) administration on NAc spine number and locomotor behavior was also measured in βAdd WT and KO mice. As expected, there was a significant increase in overall spine density in NAc slices from cocaine‐treated WT mice at this time‐point; however, there was a greater increase in the density of mushroom spines in βAdd‐KO animals following chronic cocaine administration than in WT. In addition, βAdd‐KO mice showed elevated locomotor activity in response to cocaine treatment compared to WT siblings. These results indicate that βAdd is required for stabilising mature spines under basal conditions in the NAc, but that lack of this protein does not prevent synaptic remodeling following repeated cocaine administration. In addition, these data are consistent with previous studies suggesting that βAdd may normally be involved in stabilising spines once drug‐ or experience‐dependent remodeling has occurred.